Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 48,528 shares at $46.84 ($2.3M) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $2.3M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.78 | 4,906 | $230K | 10.1% |
| 2 | $46.78 | 4,906 | $230K | 10.1% |
| 3 | $46.84 | 12,947 | $606K | 26.6% |
| 4 | $46.84 | 12,947 | $606K | 26.6% |
| 5 | $47.17 | 1,349 | $64K | 2.8% |
| 6 | $47.17 | 1,349 |
| $64K |
| 2.8% |
| 7 | $47.33 | 800 | $38K | 1.7% |
| 8 | $48.83 | 96 | $5K | 0.2% |
| 9 | $49.21 | 200 | $10K | 0.4% |
| 10 | $46.08 | 1,166 | $54K | 2.4% |
| 11 | $46.08 | 1,166 | $54K | 2.4% |
| 12 | $47.28 | 1,842 | $87K | 3.8% |
| 13 | $47.28 | 1,842 | $87K | 3.8% |
| 14 | $47.76 | 1,506 | $72K | 3.2% |
| 15 | $47.76 | 1,506 | $72K | 3.2% |
| Total | $46.92 avg | 48,528 | $2.3M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |